Gaps in Lung Cancer Treatment Persist, Yale Study Finds“In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA Network Open,...
FDA Approves Monthly Dosing for Subcutaneous Amivantamab in EGFR-Mutated NSCLC“The U.S. Food and Drug Administration has approved a once-monthly dosing schedule for frontline amivantamab and hyaluronidase-lpuj (Rybrevant Faspro), the subcutaneous formulation of the...
Will Offering a Blood Test to Detect Lung Cancer Improve Screening Rates?“Dr. Melinda Aldrich wants to boost screening rates to catch lung cancer earlier when it is more treatable.” Tuberculosis, Chronic Bronchitis Linked to Lung Cancer Risk in Never-Smokers“A...
‘Personal lives’ of lung cancer cells help predict response to treatment“University of Queensland researchers who mapped cancer cell “neighborhoods” in the most common type of lung cancer have found cell metabolism plays a critical role in...
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial“In summary, our study indicates that early ToD immunochemotherapy substantially improves PFS and OS and is associated with enhanced antitumor CD8+ T cell characteristics compared...
More News and Updates